Shaping the Future World of Health

In comes Precision Medicine (PM), which utilizes modern technological approaches such as big data analysis, artificial intelligence and additive manufacturing, to name just a few. As a contemporary answer to an age-old problem, PM holds the promise of tailoring therapeutic approaches to specific patients, their unique biography and even their DNA. The question is, can it live up to the hype?

In its brand-new series on “Precision Medicine” (June 2018 to December 2019), the German Center for Research and Innovation examines the four core areas: (1) diagnostics, (2) data mapping of diseases, (3) targeted therapies and, finally, (4) individualized drugs. This exchange of new knowledge, ideas and solutions among all stakeholders will contribute to a transatlantic dialogue between the US and Germany on science, teaching, corporate work, policy support and patient´s expectations.
The inaugural event, June 13, will set the stage by looking at the big picture: What can we expect from precision medicine? Where are we headed in the future world of health? Join the discussion with experts from the universities of Freiburg and Rochester, the Dana-Farber Cancer Institute and the two global pharma companies Pfizer, USA, and Bayer, Germany!

Panelists

Prof. Dr. Christoph Borner
Institute of Molecular Medicine, University of Freiburg and Eucor, The European Campus

Dr. Hubert Pakula
Dana-Farber Cancer Institute

Prof. Dr. Hartmut Land
University of Rochester

Dr. Marion Hitchcock
Bayer AG, Strategic Alliance Management

Dr. David J. Shields
East Coast Centers for Therapeutic Innovation, Pfizer Worldwide Research & Development, New York

moderated by

Dr. Markus Lemmens
University of Freiburg and Eucor, The European Campus, New York Office